QuarterlyIQ Insights · ALB
Price
Price, valuation, and the composite score on the same time axis. Scroll over the price chart to zoom.
Price
Daily closes. Earnings/event dots inline.
What it's worth (estimated)
A consensus fair price across 6 valuation methods, at three horizons. Current price $152.80. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
No-growth: today's peer multiple on trailing earnings. The headline read.
Embeds projected growth. Leans optimistic by design. Upside context.
Long-thesis check; widest uncertainty.
By method
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Conf. |
|---|---|---|---|---|---|---|
| Mgmt guidance | 12M | $99.73 | 24.3 | 4.10 | Mgmt | 48 |
| Peer P/FCF | 12M | $146.91 | 29.9 | 4.91 | TTM | 48 |
| Peer P/E | 12M | $56.92 | 24.3 | 2.34 | TTM | 48 |
| Peer P/S | 12M | $100.06 | 2.3 | 43.92 | TTM | 48 |
| Own P/E history | 12M | $93.41 | 39.9 | 2.34 | TTM | 48 |
| triangulated | 12M | $61.35 | 24.3 | 2.52 | Triangulated | 48 |
| Peer P/FCF | 3Y | $86.80 | 29.9 | 2.90 | Hist. CAGR(prov.) | 46 |
| Peer P/S | 3Y | $152.43 | 2.3 | 66.91 | Analyst | 46 |
| Peer P/FCF | 5Y | $61.11 | 29.9 | 2.04 | Hist. CAGR(prov.) | 47 |
| Peer P/S | 5Y | $201.81 | 2.3 | 88.59 | Analyst | 47 |
Composite score history
Daily snapshots of the composite. Zero is the dotted line. Above it leans positive.
P/E history
Monthly trailing P/E with quartile reference lines.
Composite score history currently shows a rolling 60-day window. We're extending it back through full coverage and adding a “consensus-then vs. actual-now” overlay (what our valuation estimate said on a past date versus where the price actually landed).
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.